Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

RBFOX1 Mouse anti-Human, Clone: OTI1F7, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA526582

Catalog No. PIMA526582


Add to cart

Description

Description

Ataxin-2 binding protein 1 has an RNP motif that is highly conserved among RNA-binding proteins. This protein binds to the C-terminus of ataxin-2 and may contribute to the restricted pathology of spinocerebellar ataxia type 2 (SCA2). Ataxin-2 is the gene product of the SCA2 gene which causes familial neurodegenerative diseases. Ataxin-2 binding protein 1 and ataxin-2 are both localized in the trans-Golgi network. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been found but their full length nature has not been determined.
Specifications

Specifications

RBFOX1
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q9NWB1
2BP1, A2BP1, FOX-1, FOX1, HRNBP1, RNA binding protein fox-1 homolog 1, ataxin 2-binding protein 1, fox-1 homolog A, hexaribonucleotide-binding protein 1
Mouse
IgG1
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
54715
Immunohistochemistry (Paraffin), Western Blot
OTI1F7
Unconjugated
RBFOX1
Liquid
RBFOX1
Human recombit protein fragment corresponding to amino acids 1-210 of RBFOX1 produced in E.coli
Affinity Chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit